DermTech, Inc.
DermTech, Inc. (DMTKQ) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DMTKQ · as of Jun 9, 2026
Key Statistics
Explore DermTech, Inc. Data
dmtkq stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 0.0%
Competitors & Peers
dmtkq competitorsDMTKQ
ABMC
AHPIQ
CRYO
ERUC
GTHRStock Performance
Full HistoryAbout DermTech, Inc.
DermTech, Inc. operates as a molecular diagnostics firm specializing in developing and commercializing innovative, non-invasive genomic tests designed to assist in the early detection and ongoing mana…
what is dermtech, inc. · dmtkq stock overview · dermtech, inc. company profile · who is dermtech, inc. ceo · dmtkq OTC · dermtech, inc. headquarters · dermtech, inc. business segments
About Stock Overview & Key Data
DermTech, Inc. (DMTKQ) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on OTC since Aug 10, 2017. As of the latest trading session, DMTKQ stock price is $0.00, with a market capitalization of $3,496. The stock has returned -99.73% over the past 12 months and +0.00% year-to-date.
According to 3 Wall Street analysts, the consensus rating for DermTech, Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2023, DermTech, Inc. reported revenue of $15.3M and net income of -$100.9M. For detailed data — including DermTech, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, DermTech, Inc. (DMTKQ) stock price is $0.00. The stock is traded on OTC under the ticker symbol DMTKQ. The 52-week range is $0.00 – $0.06.